Prostate cancer uses metabolic switch to thrive after hormone therapy

Prostate cancer uses metabolic switch to thrive after hormone therapy

Studying the cellular metabolism of prostate cancer, a team of Duke Health-led researchers identified a key reason hormone therapies eventually fail, while also laying out a way...

New Technology that Pinpoints Prostate Cancer Will Transform Care

New Technology that Pinpoints Prostate Cancer Will Transform Care

Prostate cancer treatment is on the brink of a major advance, thanks to new imaging technology that can pinpoint the location of prostate cancer cells. This new diagnostic tool...

Resistance to second-generation androgen receptor antagonists in prostate cancer

Resistance to second-generation androgen receptor antagonists in prostate cancer

Resistance to second-generation androgen receptor antagonists in prostate cancer Prostate cancer Abstract The introduction of second-generation androgen receptor antagonists...

Recent Advances in Epigenetic Biomarkers and Epigenetic Targeting in Prostate Cancer

Recent Advances in Epigenetic Biomarkers and Epigenetic Targeting in Prostate Cancer

In addition to genetic alterations, epigenetic alterations play a crucial role during prostate cancer progression. A better understanding of the epigenetic factors that promote...

Freezing prostate cancer: Study shows notable outcomes with cryoablation

Freezing prostate cancer: Study shows notable outcomes with cryoablation

A less-invasive treatment technique called hemi-gland cryoablation (HGCryo) – destroying the areas of the prostate where cancers are located by freezing them – provides a high...

CASC11 promotes aggressiveness of prostate cancer cells through miR-145/IGF1R axis

CASC11 promotes aggressiveness of prostate cancer cells through miR-145/IGF1R axis

prostate cancer and prostatic diseases Abstract Background Prostate cancer (PCa) is the most common malignancy diagnosed among men after lung cancer in developed countries....

Kinesin family member 18B regulates the proliferation and invasion of human prostate cancer cells

Kinesin family member 18B regulates the proliferation and invasion of human prostate cancer cells

cell death & disease Cell Death & Disease volume 12, Article number: 302 (2021) Cite this article 1 Altmetric Prostate cancer Abstract Expression of kinesin family member 18B...

With many prostate treatment options available, which one is the best for you?

With many prostate treatment options available, which one is the best for you?

Prostate Cancer Staging Making Treatment Decisions Prostate cancer affected close to 200,000 men in 2020. The prognosis of prostate cancer is usually positive because it...

Prostate Cancer Spread to Bones: Life Expectancy and More

Prostate Cancer Spread to Bones: Life Expectancy and More

When prostate cancer spreads, the bones are typically the first area affected. Bone metastases can weaken your bones and lead to symptoms like bone pain. There’s no cure for...

Cancer Trial Participation Does Not Eliminate Disparities for Poor Patients

Cancer Trial Participation Does Not Eliminate Disparities for Poor Patients

Cancer Trial Participation Does Not Eliminate Disparities for Poor Patients March 18, 2021 San Francisco, CA (UroToday.com) -- Even with access to a clinical trial, cancer...

Sleep Disorders and Cancer: State of the Art and Future Perspectives

Sleep Disorders and Cancer: State of the Art and Future Perspectives

Sleep Disorders and Cancer: State of the Art and Future Perspectives - Beyond the Abstract March 17, 2021 There is a two-way connection between sleep and cancer; however, the...

Test May Show Whether to Treat Prostate Cancer with Hormones

Test May Show Whether to Treat Prostate Cancer with Hormones

A large study has confirmed that a genetic test can correctly predict how likely it is for recurrent prostate cancer to spread (metastasize) to other parts of the body. The test...